| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-09 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.47 | 0.0001 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |